328 related articles for article (PubMed ID: 32044978)
1. A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry.
Batthish M; Berard R; Cabral D; Bolaria R; Chédeville G; Duffy C; Gerhold K; Gerschman T; Huber A; Proulx-Gauthier JP; Rosenberg A; Rumsey D; Schmeling H; Shiff N; Soon G; Bruns A; Tucker L; Guzman J;
Rheumatology (Oxford); 2020 Oct; 59(10):2796-2805. PubMed ID: 32044978
[TBL] [Abstract][Full Text] [Related]
2. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.
Guzman J; Oen K; Tucker LB; Huber AM; Shiff N; Boire G; Scuccimarri R; Berard R; Tse SM; Morishita K; Stringer E; Johnson N; Levy DM; Duffy KW; Cabral DA; Rosenberg AM; Larché M; Dancey P; Petty RE; Laxer RM; Silverman E; Miettunen P; Chetaille AL; Haddad E; Houghton K; Spiegel L; Turvey SE; Schmeling H; Lang B; Ellsworth J; Ramsey S; Bruns A; Campillo S; Benseler S; Chédeville G; Schneider R; Yeung R; Duffy CM;
Ann Rheum Dis; 2015 Oct; 74(10):1854-60. PubMed ID: 24842571
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry.
Semalulu T; Berard R; Beattie K; Basodan D; Boire G; Bolaria R; Cabral D; Chhabra A; Gerschman T; Johnson N; Herrington J; Houghton K; Lim L; Miettunen PMH; Park J; Proulx-Gauthier JP; Schmeling H; Scuccimarri R; Tam H; Tucker L; Guzman J; Batthish M;
J Rheumatol; 2024 Apr; 51(4):403-407. PubMed ID: 38302168
[TBL] [Abstract][Full Text] [Related]
4. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
Kimura Y; Grevich S; Beukelman T; Morgan E; Nigrovic PA; Mieszkalski K; Graham TB; Ibarra M; Ilowite N; Klein-Gitelman M; Onel K; Prahalad S; Punaro M; Ringold S; Toib D; Van Mater H; Weiss JE; Weiss PF; Schanberg LE;
Pediatr Rheumatol Online J; 2017 Apr; 15(1):23. PubMed ID: 28399931
[TBL] [Abstract][Full Text] [Related]
5. Down Syndrome-Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes.
Jones JT; Smith C; Becker ML; Lovell D;
Arthritis Care Res (Hoboken); 2021 Dec; 73(12):1739-1745. PubMed ID: 33242376
[TBL] [Abstract][Full Text] [Related]
6. Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children.
Tiller G; Buckle J; Allen R; Munro J; Gowdie P; Cox A; Akikusa J
Pediatr Rheumatol Online J; 2018 Nov; 16(1):69. PubMed ID: 30413164
[TBL] [Abstract][Full Text] [Related]
7. The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.
Beukelman T; Kimura Y; Ilowite NT; Mieszkalski K; Natter MD; Burrell G; Best B; Jones J; Schanberg LE;
Pediatr Rheumatol Online J; 2017 Apr; 15(1):30. PubMed ID: 28416023
[TBL] [Abstract][Full Text] [Related]
8. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry.
Schmeling H; Minden K; Foeldvari I; Ganser G; Hospach T; Horneff G
Arthritis Rheumatol; 2014 Sep; 66(9):2580-9. PubMed ID: 24942886
[TBL] [Abstract][Full Text] [Related]
10. Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis.
Barber CEH; Barnabe C; Benseler S; Chin R; Johnson N; Luca N; Miettunen P; Twilt M; Veeramreddy D; Shiff NJ; Schmeling H
Pediatr Rheumatol Online J; 2020 Mar; 18(1):22. PubMed ID: 32143720
[TBL] [Abstract][Full Text] [Related]
11. Cumulative Damage in Juvenile Idiopathic Arthritis: A Multicenter Study From the Pediatric Rheumatology Arab Group.
Al-Mayouf SM; Hashad S; Khawaja K; Alrasheedi A; Abdwani R; Abushhaiwia A; AlSuwaiti M; Alzyoud R; Al Abrawi S; Asiri A; Alshaikh M; Sharif E; Muzaffer M; Alsewairi W; Zlenti M; Kawaja E; Almutairi M; Majeed M; Lotfy H; AlMarri M; Almutairi N;
Arthritis Care Res (Hoboken); 2021 Apr; 73(4):586-592. PubMed ID: 32886859
[TBL] [Abstract][Full Text] [Related]
12. Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Beukelman T; Lougee A; Matsouaka RA; Collier D; Rumsey DG; Schenfeld J; Stryker S; Twilt M; Kimura Y;
Pediatr Rheumatol Online J; 2021 Aug; 19(1):131. PubMed ID: 34419107
[TBL] [Abstract][Full Text] [Related]
13. Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project.
Ringold S; Hendrickson A; Abramson L; Beukelman T; Blier PR; Bohnsack J; Chalom EC; Gewanter HL; Gottlieb B; Hollister R; Hsu J; Hudgins A; Ilowite NT; Klein-Gitelman M; Lindsley C; Lopez Benitez JM; Lovell DJ; Mason T; Milojevic D; Moorthy LN; Nanda K; Onel K; Prahalad S; Rabinovich CE; Ray L; Rouster-Stevens K; Ruth N; Shishov M; Spalding S; Syed R; Stoll M; Vehe RK; Weiss JE; White AJ; Wallace CA; Sobel RE
Arthritis Care Res (Hoboken); 2015 Apr; 67(4):529-37. PubMed ID: 25331530
[TBL] [Abstract][Full Text] [Related]
14. Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Mannion ML; Xie F; Horton DB; Ringold S; Correll CK; Dennos A; Beukelman T;
J Rheumatol; 2021 Aug; 48(8):1322-1329. PubMed ID: 32934124
[TBL] [Abstract][Full Text] [Related]
15. Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans.
Kimura Y; Schanberg LE; Tomlinson GA; Riordan ME; Dennos AC; Del Gaizo V; Murphy KL; Weiss PF; Natter MD; Feldman BM; Ringold S;
Arthritis Rheumatol; 2021 Oct; 73(10):1898-1909. PubMed ID: 34105312
[TBL] [Abstract][Full Text] [Related]
16. Comparing Canadian paediatric rheumatology practice to the 2019 ACR Juvenile Idiopathic Arthritis guidelines: results from the CAPRI Registry.
Park J; Batthish M; Berard RA; Chédeville G; Proulx-Gauthier JP; Rumsey DG; Tucker LB; Wong S; Guzman J;
Rheumatology (Oxford); 2023 Apr; 62(4):1616-1620. PubMed ID: 35977388
[TBL] [Abstract][Full Text] [Related]
17. Medical pathways of children with juvenile idiopathic arthritis before referral to pediatric rheumatology centers.
Freychet C; Lambert C; Pereira B; Stephan JL; Echaubard S; Merlin E; Chausset A
Joint Bone Spine; 2019 Nov; 86(6):739-745. PubMed ID: 31121314
[TBL] [Abstract][Full Text] [Related]
18. Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry.
Foeldvari I; Becker I; Horneff G
Arthritis Care Res (Hoboken); 2015 Nov; 67(11):1529-35. PubMed ID: 25988824
[TBL] [Abstract][Full Text] [Related]
19. A decade of progress in juvenile idiopathic athritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry.
Nguyen K; Barsalou J; Basodan D; Batthish M; Benseler SM; Berard RA; Blanchette N; Boire G; Bolaria R; Bruns A; Cabral DA; Cameron B; Campillo S; Cellucci T; Chan M; Chédeville G; Chetaille AL; Chhabra A; Couture J; Dancey P; De Bruycker JJ; Demirkaya E; Dhalla M; Duffy CM; Feldman BM; Feldman DE; Gerschman T; Haddad E; Heale L; Herrington J; Houghton K; Huber AM; Human A; Johnson N; Jurencak R; Lang B; Larché M; Laxer RM; LeBlanc CM; Lee JJY; Levy DM; Lim L; Lim LSH; Luca N; McGrath T; McMillan T; Miettunen PM; Morishita KA; Ng HY; Oen K; Park J; Petty RE; Proulx-Gauthier JP; Ramsey S; Roth J; Rosenberg AM; Rozenblyum E; Rumsey DG; Schmeling H; Schneider R; Scuccimarri R; Shiff NJ; Silverman E; Soon G; Spiegel L; Stringer E; Tam H; Tse SM; Tucker L; Turvey S; Twilt M; Duffy KW; Yeung RSM; Guzman J;
Rheumatology (Oxford); 2023 Oct; ():. PubMed ID: 37851400
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and Safety of High-Dose Biologics in Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance.
Correll CK; Shrader P; Dennos A; Phillips T; Shiff NJ; Verstegen RHJ; Beukelman T;
Arthritis Care Res (Hoboken); 2022 Nov; 74(11):1770-1779. PubMed ID: 34121344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
